Overview A synthetic, non-hormonal, anti-inflammatory, antipyretic compound for the relief of equine inflammatory conditions associated with the musculoskeletal system.

  • FDA approved
  • Administered IV
  • Response to phenylbutazone therapy is prompt, usually occurring within 24 hours
  • In animals, phenylbutazone is largely metabolized in 8 hours